HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


GAO Backs Prescription Pseudoephedrine Approach

This article was originally published in The Tan Sheet

Executive Summary

Senator Feinstein says PSE products should be available only by prescription nationwide. A GAO report supports “an expansion of prescription-only laws in the fight to combat the serious epidemic of meth production,” she says.

You may also be interested in...

NPLEx Pays Dividends In Stopping Multi-State PSE Purchases

The largest amount of NPLEx-stopped sales was in Texas – 209,000 grams or 82,000 boxes. “People who don’t know the tracking system is in effect are still trying to purchase over the legal limit across state lines,” says National Association of Drug Diversion Investigators Executive Director Charles Cichon.

Congress, Missouri Enhance Meth Enforcement

Efforts to further tighten controls on sales of OTC methamphetamine precursors get a boost nationwide from Congress and in Missouri from a state law

Dr. Teal’s Tucks In Some Melatonin Topical Sleep Claims After P&G Challenge, Keeps Others Awake

PDC Brands declines to provide support for nine challenged claims for Dr. Teal’s line of balms, lotions, oils, soaps, sprays and other topicals. It continues using those after halting use of 25 other similar claims challenged by P&G, marketer of melatonin-containing ZzzQuil.


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts